博瑞医药: 关于“博瑞转债”预计满足赎回条件的提示性公告

Group 1 - The company issued 4.65 million convertible bonds with a total value of 465 million RMB, which began trading on January 27, 2022 [1] - The conversion price of the bonds was adjusted from 35.56 RMB to 35.05 RMB on December 6, 2022, due to the company's annual equity distribution [3] - The conversion price will continue to be adjusted based on annual equity distributions, with the next adjustment scheduled for July 2024 [3] Group 2 - The redemption terms allow the company to redeem the bonds if the stock price remains above 130% of the conversion price for at least 15 out of 30 trading days [5] - The company will decide on redemption based on stock performance from August 22 to September 4, 2025, with a potential trigger for the redemption clause [5]